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files were quantified using glyoxylic acid (SPG)-inducad histofluorescence
and immunohlstochemical staining of neuropeptide Y (NPY), a sympathetic
neurotransmitter which is co-released with NE.
Control Norepinephrirre
Vlts Placebo Vits Placebo
Plasma NE 0.3s i 0.09 0.50 * 0.05 1,78 & 0.28 2,08 + 0,46
NE uptake 64.9* 6.7 65.0 + 7.6 57.6 k 6.2 43.1 & 5,2++
SPG 137.8 l 11.9 140.3 + 10.1 125.5 + 12.1 S8.4+ &4*+
NPY 87.9 & 6.8 99,3 k4,3 t02.6+ 7.4 45.9+3.1”+
(*Ps 0.05 versus controlgroup;‘ps 0.05 versus NE+vits group)
Antioxidant attenuated the decrease in cardiac NE uptake activity and
loss of sympathetic naurotransmitters caused by excess NE. These findings
implicate NEderivad oxygen free radicals in cardiac noradrenergic dysfunc-
tion and thus, suggest a potentially therapeutic role for antioxidant vitamins
In CHF.
1083-117 TheEndogenousNatriureticPeptldeSystem
ModulatesDiastolicFunctionin Experimental
HeartFailure
Kazuhiro Yamamoto, John C. Burnett Jr., Margaret M. Radfield. Mayo
Clinic, Rochester, MN, USA
Atrial and brain natriuretic peptides (of myocyte origin) and C-type natriuretic
peptides (of endothelial origin) are vasoactive peptides whosa production
by the heart is enhanced In heart failure (HF). Natriuretic peptide (NP)
receptors have beendemonstratedonLV myocytes and in-vitro studies have
suggested that cGMP,the NP second mesaenger, hes effects on myocardial
function. Therefore, we hypothesized that the endogenous NP system acts
as an autocrine/paractfne system to modulate LV function in HF. To test this
hypothesis, HS-142-1 (HS), a apecific antagonist of the NP receptors, was
infused into the coronary arteries in 5 dogawith chronic HF produced by rapid
ventricular pacing at doaee dasignad to produce selective blockade of the
intracardiac NP system without systemic effects. Heart rate was controlled
by atrial pacing during the infusion. The time constant of LV relaxation (Tau),
the time to the onset of LV relaxation (t), mean aortic pressure (mAoP), LV
end-diastolic pressure (LVEDP)and peak+ dP/dt were measured (*ps 0.05
vs Control, ‘ps 0.05 vs HS dose 1)
Control HS doss 1 HS dose2
mAoP (mmHg) 76+ 6 79& 7 63 k 10
LVEDP (mmHa) 15+6 16+S 17+6
Peak & dP/dt &mH@) 1147 * 212 1199 + 238 1202 * 244
Tau (ins) 39* 7 45* 7’ 49 *8**
t (ins) 22s * 12 238 & 15” 243* 16*
Antagonism of the intracardiac NP system in HF prolonged t and Tau
without effects on loading conditions or inotropic function.
Conckrsions: In HF, the activated endogenous NP syatem functions in
the heart as an autocrine/paracrine system to enhance LV diastolic function
by accelerating LV relaxation These data indicate that the NP system is an
important bcal regulator of cardiac function in HF.
1083-118 TheSynergisticEffectsof VitaminE and
SeleniumonCardiecAntioxidantLevelsine
Modelof IronOverloedCardiomyopathy
W.J. Bartfay, F. Dawood, W.-H. Wen, E. Barffay, M.J. Sole, N. Oliviari,
P.Backx, P.Liu. The TorontoHospital, Center for CVReaearch, University
of Toronto, Toronto, Canada
Iron overtoed cardiomyopathy is a prototype of restrictive cardiomyopathy,
and is a common cauaa of heati failure in young patients worldwide. Oxygen
free radical (OFR) production may be pathogenic in heari failure of diverse
etiology, including iron overload cardiomyopathy. The myocardium has sev-
ersl intrinsic antioxidants to defend againstfraa radicals, including glutathione
peroxidase (GPx), selenium (Sa) and vitamin E (Vit E). The deficiancias of
the Iatter?spacias are known to cause heart failure. Redetermined whether
chronic supplementation of Vit E and Se can improve myocardial antioxidant
defenses inamodel of iron overload cardiomyopathy. Ironovarioad state was
created in B6D2FI mice by iron dextran injection (5 mg i.p.) daily for4 weeks.
The animals were simultaneously randomized to receive Vit E (a-tocopherol
40 mg i.p.) or Sa (aOdiumselenita 1 ppm P.o.) supplementation individually
or both togethar (Vit E+Se) for 4 weeks (n = 20), vs. DIOW p.o. as controla
(n= 5). The hearts were harvested for determination of GPx (pmol/L) and
SE levels (nmol/L). All data presented as maan + SD:
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Control Vlt E Se Vit E + Se
GPx 162 + 9S 152 +72 175 +66 346 + 126**
Se 87*26 96+31 775 *74 725 h 968*”
“p <0.001 comparedto controlor individualVit E & Se groups.
We corrclude that vitamin E and selenium may function synergistically
in the myooardium to provide important antioxidant defense mechanisms
againat free radical damage, such as found in Iron overload and hean failure.
These elements may also have therapeutic implications in theae renditions.
11083-1191AngloganlcFactorsBasicFNwoblastGI’owth
FactorandAngiogenininAdvancedHeart
FailurePatients
D.M. Farrnakis, P.D.Papedopouloa, E.V. Economou, M.G. Toutouza,
K.1.Kapetanios, D.P.Papedopoulos, T.A. Argiriou, P.K.Toutouzas.
Cardiology Clinic, University of Athens, Hippokration Hoapit8/,Athens,
Greece
There are rrtanydatawhich suppoflthat in advanced heart failure (HF)occurs
neovascularisation and hyperplaaia of cardiac myocyfes both disproportion-
ate to the hyperfrophy. Basic Fibroblast Growth Factor (bFGF), a multifunc-
tional polypeptide which has been localised to adult cardiac myocytes in vitro,
haa angiogenic properties and stimulate proliferation of cardiac myocytes,
endothelial cells etc. Angiogenin (ANG), a non glycosylated polypeptide, so
named for its strong ability to induce new blood vessel growth,but its pre-
cise role in heart diseaseshas not yet been well clarified. The aim of our
study was to investigate any possible role of bFGF and ANG in patients with
heart failure. We studied 50 patients with HF, 41 men, mean age 60 years,
and 9 women, mean age 66 years, of different aetiology - cororra~ hearl
disease (CHD) 2W50, dilated cardiomyopathy(DCM) 11/50, valvulopathy
(VHD) 14/51-, and all classes of NYHA (Class I 8/50, Class II 6150,Class Ill
14/50, Class IV 22/50) and compared to 21 healthy controls (17 men and 4
women age-matched). Patients with acute or chronic inflammatory disease,
malignancies, collagen disease, thyroid, renal or liver diseaae, hypertension
or diabetes mellitua have been excluded from our study. Before sampling pa-
tients were clinically ateble and off medication, except diuretica, for a period
of 5 days. Samplas wara maaaured by relevant ELISA kits. For the statistical
analysia t-test for unpaired differences (p) was uaed. Results expressed as
mean values + SEM:
Controls Classes Class Class Class class DCM VHD CHD
I-W I II Ill Iv
bFGF 1.95+ 5.69+ 3.14+ 3.74* 4.17+ 8,09+ 4.56+ 4.76* 7.57*
(pg/ml) 0.3S 0.79” 0.92 1.65 1.4* 1.32* 1.13* 1,22* 1,46*
ANG 249.8+ 325.0+ 237* 297.8A 319.2+ 335,4& 320.3* 311.6+ 336.6zt
(rig/ml) 11.6 14.2” 21.2 34.6 23.6* 20,s” 27* 20.2” 23.8”
*p c 0.05 comparedwithcontrols
In conclusion, in end-staga HF patients there is a statistically significant
increase in plasma levels of angiogenic factors bFGF and angiogenin. The
progressive increase of plasma levels of bFGF and ANG suggest a dynamic
continuous process poasibly in naovascularisation. The clinical implication of
this phenomenon in congestive HF needs further investigation.
11083-12OI CachexiainChronicHeartFailure:Leptin
MediatedAnorexiaor CytokineandHormone
Action?
S.D. Ankerl, K.R. Egerer2, M,M. Teixeiral, P.G.Hellewell 1,
P.Ponikowski 1, P.A. Poole-Wilaon1,W.J. KOX2,A.J.S. Coats 1.1 NHL/,
London, UK, 2Dept of Anaasthesio/ogy Charite Berfin, FRG, Germany
The oeuea of cardiac cachexia is not clear. Tha peptida laptin playe a role
in obesity (Ieptin resistance), but alao in weight loss during infaction (Ieptin
overexpression due to TNF-a and endotoxin action, subsequently anorexia).
We aimed to relate body composition changaa (dual x-ray absorptiometry,
lean and fat tissue in relation to haight) to cytokine, hormone, Ieptin, and
soluble [s] CD14 levels (indicative of LPS cell interaction) in 46 CHF patients
(age61 +2y, LVEF26 + 2%, NYHAclass 2.7 + 0.1) and 21 healthy controls
(57 + 2y, p = 0.15). Leptin (p < 0.02), noradrenalina [NA], sTNF receptor 1,
IL-6, sCD14 (all p < 0.004) and insulin (p < 0.03) were increased in CHF.
Nineteen patients were oechectic ([c] dry weight loss 12 + 2 kg over z 6
months, particularly increaead TNFxz, sTNF-RI, sCD14, and NA).
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Contr ncCHF cCHF ncCHF cCHF cCHF
vs Con vs Con vs ncCHF
n =21 n =29 n = 19 (P=) (P=) (P=)
sTNF.RI. nalml 0,6 + 0.061.1 + 0.18 1.7+ 0.170.03 0.02 <0.0001. . .. .... ....
sCD14, @/ml 2.7 + 0.11 3.2+ 0.16 3.8+23 0.07 0.0001 0.009
Leptin,n@ml 4.8 + 0.7 9.4+ 1.1 5.3+ 0.7 0.0005 NS 0,002
BodyFaffheight,@cm 106+10 123+9 60+ 5 0.20 0.03 0,0006
BodyLaatiheight, #cm 327 i 6 326 & 7 270 + 5 NS <0.0001 <0.0001
mean + SEM, nc = non-cechactlc,NS = p >0.20
overall, Ieptin correlated with fat tissue content (r = 0.70), ineulin (r =
0.72), weight and BMI (all p c 0.0001), but no! with cytokinee. Fat tiseue
content ve insulin (r= 0.49, p c 0.0001), vs sTNF-RI (r= –0.37), ve NA (r =
-0.34, troth p < 0.006). Lean tissue content sTNF-RI (r= –0.41), vs NA (r
= -0.39), veTNF-u (r = –0.36, all p < 0.003).
Corrclusiom Cardiac cachexia is not characteriead by Ieptin overproduc-
tion (anorexia via thie pathway is unlikely), but ie rather a Cataboliccondition
related to immune and neurohormonal activation.
m1083121 DiagnosticsndPrognosticValuaof SolublaInterleukin2 ReceptorintheSerumof Patients
withIdiopathicor lschemicDilated
Cardiomyopathy
G. Klappacher, D. Haab, M. Mehrabi, K. Plesch, R. Pacher, W. Kukutschki,
H.D. Glogar. University of Vienna, Vienna, Austria
We and others have recently reportad that circulating levels of soluble ln-
terleukin 2 receptor (sIL2R) are increased in patients with idiopathic dilated
cardiomyopathy suggesting cellular autoimmune activation. In the present
etudy we looked at the specificity, the diagnostic and predictive value of
serum sIL2R. In agreement with previous observations, 34 patients with
idiopathic dilated cardiomyopathy had higher Ievele of elL2R than healthy
controls (756 + 76.6 vs. 461.2 + 35.9 U/mL, p -=0.01). All 5 deaths during
the follow-up period of 690 * 57 days occurred among the patients with
serum elL2R >750 U/mL (log rank test, p e 0.00001), who also were more
likely to receive a heart transplant (odds ratio 6.5 (1.3-357.9)). Moreover,
patienta in NYHA claeeee Ill and IV, with eerum eodium <136 mmol/L and
furoeemide doeage z 100 mgfday had significantly higher serum concentra-
tion of sI12R than patiente in NYHA claesee I and 11,with eerum sodium ?
136 mmoVL and furosemide dosage <100 m~day, respectively. In 24 pe-
tiente with ieehemic cardiomyopathy eerum sIL2R was also increased above
control levels (619.7 + 36.3 U/mL, p c 0.025), but it was not associated
with the clinieel stage. Neither in ischemic nor in idiopathic dilated cardiomy-
opathy serum sIL2R correlated with the counts of CD2-, CD3-, CD4-, CD6-,
CD46R0-, and lL2R-positive cells in croee eecfione of the explantad hearte
of 15 transplant recipients among the total of 66 patients. Conclusion: Serum
sIL2R pradiete death and indicatee progression of dieeeee in patients with
idiopathic dilated cardiomyopathy. However, its increaae is not mnfinad to
the idiopathic form and does not necessarily reflect immune activation in the
myoeerdium.
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m1084135 LeftVentricularHypertrophylaAssociatedwithAbnormalAdenoalneAl-ReceptorSignalingand
Adenostne-inducedProteinKinaaeC Activation
S. Perlinl, E.P. Khoury, E.S. Chung, F. Bartl, R.A. Fenton, J.G. Dobeon,Jr.,
T.E. Meyer. Urriversityof Massachusetts Medical Cantec Worcester MA,
USA
To aesees the effect of prolonged adenosine (Ado) infueion on adrenergic
reeponsivensse (AR) in left ventricular hypartrophy (LVH), rat hearta were
isolated and perfused at 10 wke after aortic banding (B, heart weight index
increased by 50Yo) or sham surgery (S). AR (+dP/dk~) to 10-8 M isopro-
terenol was determined before (C) and at 60 min of 3.3 x 10-5M of Ado or
NaCl infueion, andafter 15, 30and45min of Ado waeh-out(tVO). Responses
were expressad as a % of C. This protocol was repeated with Ado and a)
a eeleetive AI antagonist, 6-cyclopentyl-1,3-diproPYlxanthine(lO-eM, CPX),
b) a protein kinase C (PKC) inhibitor, chelerythrine (2 x 10-6M, Chel) ore) a
PKC activator, phorbcd12-myristate 13-acetate (10-9M, PMA).
% dP/dt of C ‘A dP/dt of C followinaAdo WP
-w
60 mifl infusion: 15 rein: 30 mln: 45 mln:
S-NaCl (n = 7) 95+ 5 91 & 6 96% 6 96& 4
S-Ado (n= 10) 31 *6* 51 *4* 61 k 6“ 74• 9*
S-Ado +Chel (n = 13) 34* 3* S4• 5t 96 h 7t 99* 7t
S-NaCl (n =7) 97 i 4 96& 4 96& 4 99* 3
B-Ado (n =24) 50* 5*t 65+ 5*t 91 i 7t 99& 8t
B-Ado+ CPX (n =7) 56& 7“f 91 * 9t 97* 12t 101 * 14t
B-Ado + Chel (n =9) 38& 4*$ 99* fl 95* 3t 99 i 7f
B-Ado+ PMA (n = 4) 56& 7*f 60+ 7*# 67& 7** 72 & 10*#
Means k SEM; *p <0.05 vs NaCl; tp <0.05 vs S-Ado;#p <0.05 vs B-Ado.
Interstitial Ado levels returned to baseline within 5 min of WO. Ado expo-
sure in S caused a marked adrenergic depreeeion (AD) at 60 min of infusion.
AD persisted up to 45 min after Ado WO. This lingering AD was preventad
by PKC inhibition. In LVH the initial AD was Ieea marked and the rscovety
was much faeter. An Al-antagonist or a PKC inhibitor did not affeef this re-
sponse, whereas pronounced lingering AD wee elicited after PMA-induced
PKC activation. Conclusion: In LVH Al-receptor signaling and Ado-induced
PKC activation are abnormal.
I 1084-I36I AbnormalCalciumHandlingprOPerty
ProgressesfromtheAdjacentto Remote
Non-lrtfarctedMyocardiumafterMyocardial
Infarction
Y. Takemoto, M. Yoshiyama, K. Takeuchi, A. Hanateni, N. Shimizu,
H. Yamagishi, 1.Toda, J. Yoshikawa. First Department of Internal Medicine,
Osaka City IJniversifyMedical School, Osaka, Japan
Cardiac dysfunction after myocarclialinfarefion develops with time. However,
the cauae is still unknown. We have a hypothesis that abnormal calcium
handling pmpetty progresses fmm the adjacent non-infarcted left ventricle
(adjacent LV) to remote non-infarcted LV after myocerdial infarction (Ml) and
induces cardiac dysfunction. The purpose of this study was to examine the
time course of cardiac function by schoeerdiograms and gene expression in
the adjacent and remote LV and right ventricles (RV) of rate’at 1, 3 and 6
months after Ml in rate. (Each group n =6)
1 month 3 months 6 months
LVEDP ~mmHa} 22* 2** 25& 3** 26+3**
LVEDV ~m!Jkg)-’ 1.52 +0.14’”
LVEF (“A) 35+3**
LVwt (@kg) 2.16+ 0.19’
RVwt (@kg) 0.74* 0.10”
E velocity(cnVs) 84& 2
A velocity(cWS) 22+ 3
EIA 4.2 + 0.5”
E Decele (rdsz) 16.1 &2.t*
1,70+ 0.13**
30*4**
2.29 + 0.17””
0.86 *0.11””
95 *3*
16 *3*
9.5* 2.2**
22.3 h 2.6**
1.96+ 0.16**
26*4”*
2.42 & 0.20**
0,92 + 0.14””
101 *3*
12 +3*
12.3+2.1””
30.4* 1.7**
SR Ca (foid)
AdjacentLV 1.0+ 0.2 0.7 l 0.1” 0.3+0.0””
Remote LV 1.0 l 0.1 1.* 0.1 0.7 l 0.0*
Rv 1.0 i 0.2 0,7+ 0.2” 0.6 + O.l”+,.
Na-Ca (told)
AdjacentLV 1.6 + 0.2** 0.9 * 0.1 0.5+ 0.1””
Remote LV 1.9 * 0.2”’ 1.8 +0.2”” 1.0 +0.1
RV 2.0 + 0.2”” 1.6 & 0.2”” 1.1 +0.2
*P <0,05, **P < 0,01: comparedto sham operated rats
Gene expressions of fetal contractile proteins (~-myosin heavy chain,
a-ekeletal aetin, ANP) and collagen 1,Ill were highest at 1 M after Ml. In
conclusion, cardiac dysfunction, decreased gene expression of SR-Ca and
Na-Ca advanced from the adjacent to remote LV with time.
11084-137I EffecteofNitricOXideSYntha*lnhibitiononthe
VenousTonein RatawithHeatiFailure
T. Hirai, H. Asanoi, T.1.Musch, H. Inoue. ToyarrsaMedical& Pharmaceutical
University Toyama,Japan, Kanaas State Universi~ Manhattan, KS, USA
Recent studies have demonstrated that nitric oxide (NO) mcdulatee bseeline
venous tone. To determine the functional mle of NO in the regulation of va-
noustone in normal rats and rats with chronic heart failure (CHF), we etudied
the effect of NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO
synthesis, in chloralose-anesthetized Wister rats with CHF due to myoeerdlal
infarction (Ml; n = 11) (Ml eize; 41 + 5% of the left ventricular endocerdial
circumference) and sham operatad rats (SHAM; n = 10). Mean circulatory
filling preesure (MCFP), the equilibrated eystemic pressure occurring when
the circulation is arrestad by transient inflation of a balloon in the right atrium,
was meaeured before and after L-NAME (1, 3, 10, 20 mg/kg, iv.) adminis-
tration. MCFP was used as an index of total venoua capacitance. Baseline
